Advaxis

Advaxis

Advaxis

Advaxis is a biotechnology company developing the next generation of cancer immunotherapies. $ADXS
Founded
2002
Raised
$30M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Team Size
10+
Employees
the home of AI info

Contrasting of Advaxis Inc. (ADXS) and Minerva Neurosciences Inc. (NASDAQ:NERV)

Xconomy

Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy

Robotics Health
$30,000,000 Post-IPO equity
New Jersey Business Magazine

Advaxis Secures $30M Direct Placement Financing

Stock markets
The Motley Fool

Why Advaxis, Inc. Stock Rose 19.6% in May

The Motley Fool

Profit-Taking Clobbers Advaxis, Inc. in April Despite Positive PR

Health Stock markets
The Motley Fool

Here's Why Advaxis Inc.'s Stock Roared Higher in March

The Motley Fool

Why Advaxis, Inc. Shares Are Soaring 16% Today

Health Stock markets
The Motley Fool

Why Advaxis Gained 20% in 2015 --

The Motley Fool

Why Advaxis, Inc Shares are Skyrocketing Today --

Health Stock markets
The Motley Fool

Here's Why Advaxis' Stock Gained 11% in October --